Abstract：
UNASSIGNED: Addictive disorders are significant global public health burdens. Treatment uptake with these disorders is low and outcomes can be mixed. Electronic screening, brief intervention, and referral to treatment (e-SBIRT) programs have potential to improve uptake and treatment outcomes. To date, however, no prior review of the literature has been conducted to gauge the effectiveness of e-SBIRT for addictive disorders.
UNASSIGNED: We conducted a systematic review and meta-analysis of the literature concerning e-SBIRT for addictive disorders by surveying the MEDLINE, PubMed, Web of Science, Scopus, Embase, and PsycInfo databases on January 17, 2023.
UNASSIGNED: Ten articles were included at analysis reporting evaluation of e-SBIRT interventions for substance use disorders including alcohol use in a variety of settings. No articles were identified regarding treatment for behavioral addictions such as disordered/harmful gambling. Meta-analysis found e-SBIRT to be effective at reducing drinking frequency in the short term only. e-SBIRT was not found to be advantageous over control conditions for abstinence or other treatment outcomes. We identified and described common components of e-SBIRT programs and assessed the quality of available evidence, which was generally poor.
UNASSIGNED: The present findings suggest that research regarding e-SBIRT is concentrated exclusively on higher-risk substance use. There is a lack of consensus regarding the effectiveness of e-SBIRT for addictive disorders. Although common features exist, e-SBIRT designs are variable, which complicates identification of the most effective components. Overall, the quality of outcome evidence is low, and furthermore, high-quality experimental treatment evaluation research is needed.
UNASSIGNED: We conducted a systematic review and meta-analysis of the literature concerning e-SBIRT for addictive disorders by surveying the MEDLINE, PubMed, Web of Science, Scopus, Embase, and PsycInfo databases on January 17, 2023.
UNASSIGNED: Ten articles were included at analysis reporting evaluation of e-SBIRT interventions for substance use disorders including alcohol use in a variety of settings. No articles were identified regarding treatment for behavioral addictions such as disordered/harmful gambling. Meta-analysis found e-SBIRT to be effective at reducing drinking frequency in the short term only. e-SBIRT was not found to be advantageous over control conditions for abstinence or other treatment outcomes. We identified and described common components of e-SBIRT programs and assessed the quality of available evidence, which was generally poor.
UNASSIGNED: The present findings suggest that research regarding e-SBIRT is concentrated exclusively on higher-risk substance use. There is a lack of consensus regarding the effectiveness of e-SBIRT for addictive disorders. Although common features exist, e-SBIRT designs are variable, which complicates identification of the most effective components. Overall, the quality of outcome evidence is low, and furthermore, high-quality experimental treatment evaluation research is needed.
摘要：
■成瘾性疾病是重大的全球公共卫生负担。这些疾病的治疗摄取很低，结果可能是混合的。电子筛选,简短的干预，和转诊治疗（e-SBIRT）计划有可能改善摄取和治疗结果。迄今为止,然而,之前没有文献综述来评估e-SBIRT治疗成瘾性疾病的有效性.
■我们通过调查MEDLINE，对有关e-SBIRT治疗成瘾性疾病的文献进行了系统综述和荟萃分析，PubMed,WebofScience,Scopus,Embase,和PsycInfo数据库在2023年1月17日。
■在各种环境中对包括酒精使用在内的药物使用障碍的e-SBIRT干预措施的评估分析中，纳入了10篇文章。没有发现有关行为成瘾治疗的文章，例如无序/有害赌博。荟萃分析发现，e-SBIRT仅在短期内有效减少饮酒频率。没有发现e-SBIRT在禁欲或其他治疗结果方面优于对照条件。我们确定并描述了e-SBIRT计划的常见组成部分，并评估了现有证据的质量，一般都很穷。
■目前的研究结果表明，有关e-SBIRT的研究仅集中在高风险物质的使用上。关于e-SBIRT对成瘾性疾病的有效性缺乏共识。尽管存在共同特征，e-SBIRT设计是可变的，这使得最有效成分的识别变得复杂。总的来说,结果证据的质量很低，而且,需要高质量的实验治疗评价研究。
■我们通过调查MEDLINE，对有关e-SBIRT治疗成瘾性疾病的文献进行了系统综述和荟萃分析，PubMed,WebofScience,Scopus,Embase,和PsycInfo数据库在2023年1月17日。
■在各种环境中对包括酒精使用在内的药物使用障碍的e-SBIRT干预措施的评估分析中，纳入了10篇文章。没有发现有关行为成瘾治疗的文章，例如无序/有害赌博。荟萃分析发现，e-SBIRT仅在短期内有效减少饮酒频率。没有发现e-SBIRT在禁欲或其他治疗结果方面优于对照条件。我们确定并描述了e-SBIRT计划的常见组成部分，并评估了现有证据的质量，一般都很穷。
■目前的研究结果表明，有关e-SBIRT的研究仅集中在高风险物质的使用上。关于e-SBIRT对成瘾性疾病的有效性缺乏共识。尽管存在共同特征，e-SBIRT设计是可变的，这使得最有效成分的识别变得复杂。总的来说,结果证据的质量很低，而且,需要高质量的实验治疗评价研究。
